Journal
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
Volume 164, Issue 3, Pages 214-217Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/archpediatrics.2009.282
Keywords
-
Categories
Ask authors/readers for more resources
Objective: To determine whether clinical trial enrollment by itself is associated with improved outcome. Design: Retrospective cohort study. Setting: Seattle Children's Hospital from 1997 to 2005. Participants: Data were drawn from 322 patients with newly diagnosed acute lymphoblastic leukemia. Main Exposure: Enrollment in a Children's Oncology Group or Children's Cancer Group clinical trial. Main Outcome Measures: (1) Demographic variables associated with trial participation. (2) Event-free survival, which was defined as the time from initial diagnosis to either leukemia recurrence or death from any cause. Results: No outcome advantage was found for participants in a clinical trial compared with nonparticipants. Additionally, there were not demographic factors associated with increased clinical trial participation. Conclusions: Clinical trial participation does not, by itself, lead to improved outcome for pediatric patients with acute lymphoblastic leukemia in the current era. Discussions about participation in a clinical trial should focus on improvement of future therapy, not the direct benefit of the research participant.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available